Evidence map›Paper›PMID 29584567›Full record

ArticleCancer biology & therapy2018

Preliminary clinical application of an aromatase inhibitor and a gonadotropin-releasing hormone agonist combination for inoperable endometrial cancer patients with comorbidities: case report and literature review.

Mengting Dong, Su Jiang, Wenyan Tian, Ye Yan, Chao Gao, Jinping Gao, Yan Sheng, Yingmei Wang, Fengxia Xue

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer biology & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Roles of Goserelin in Gynecological Disorders.Drug design, development and therapy · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mengting Donga Department of Obstetrics and Gynaecology , Tianjin Medical University General Hospital , Tianjin , China.
Su Jianga Department of Obstetrics and Gynaecology , Tianjin Medical University General Hospital , Tianjin , China.
Wenyan Tiana Department of Obstetrics and Gynaecology , Tianjin Medical University General Hospital , Tianjin , China.
Ye Yana Department of Obstetrics and Gynaecology , Tianjin Medical University General Hospital , Tianjin , China.
Chao Gaoa Department of Obstetrics and Gynaecology , Tianjin Medical University General Hospital , Tianjin , China.
Jinping Gaoa Department of Obstetrics and Gynaecology , Tianjin Medical University General Hospital , Tianjin , China.
Yan Shenga Department of Obstetrics and Gynaecology , Tianjin Medical University General Hospital , Tianjin , China.
Yingmei Wanga Department of Obstetrics and Gynaecology , Tianjin Medical University General Hospital , Tianjin , China.
Fengxia Xuea Department of Obstetrics and Gynaecology , Tianjin Medical University General Hospital , Tianjin , China.
Tianjin Medical University General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aromatase inhibitorcomorbidityEndometrial cancerGonadotropin-releasing hormone agonistinoperable treatment

Identifiers

PMID29584567
PMCPMC6301831
OpenAlexW2795219906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.